Literature DB >> 7690377

Autoradiographic detection of substance P receptors in normal and psoriatic skin.

C Pincelli1, F Fantini, L Giardino, M Zanni, L Calzá, C Sevignani, A Giannetti.   

Abstract

Substance P has been detected in human skin and has been implicated in the pathogenesis of certain inflammatory cutaneous disorders. However, little is known about the number and distribution of substance P binding sites in the skin. Receptor autoradiography was employed to detect and quantitate substance P receptors in normal as well as psoriatic skin. Substance P binding sites were distributed in the epidermis and dermis both in normal and psoriatic skin. In the dermis, the highest densities of SP binding sites were found in the areas corresponding to the dermal papillae and the adnexal structures. Quantitative analysis revealed that saturable binding was obtained both in the epidermis and in the labeled dermal areas. Rosenthal plot values were consistent with a single population of binding sites. No difference in the binding measurements was observed between normal and psoriatic skin. The presence of substance P receptors in the epidermis and in the dermal papillae raises interesting issues on the possible targets of this peptide in human skin both under physiologic and pathologic conditions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690377     DOI: 10.1111/1523-1747.ep12365423

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  2 in total

1.  Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ.

Authors:  R Paus; T Heinzelmann; S Robicsek; B M Czarnetzki; M Maurer
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

2.  Substance P and keratinocyte activation markers: an in vitro approach.

Authors:  J Viac; A Gueniche; J D Doutremepuich; U Reichert; A Claudy; D Schmitt
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.